Souweine B, Veber B, Bedos J P, Gachot B, Dombret M C, Regnier B, Wolff M
Service de Réanimation des Maladies Infectieuses, Groupe Hospitalier Bichat-Claude Bernard, Paris, France.
Crit Care Med. 1998 Feb;26(2):236-44. doi: 10.1097/00003246-199802000-00017.
To determine whether the diagnostic accuracy of bronchoscopy samples in patients with suspected ventilator-associated pneumonia is affected by prior antibiotic treatment given for a previous infection, and/or by antibiotic treatment recently started to treat suspected ventilator-associated pneumonia.
Study of critically ill patients.
Intensive care unit in a university hospital.
Sixty-three episodes of suspected ventilator-associated pneumonia were prospectively evaluated. Based on prior antibiotic treatment, three groups were defined: no antibiotic group (no previous antibiotic treatments), n = 12; current antibiotic group (antibiotic treatment initiated >72 hrs earlier), n = 31; and recent antibiotic group (new antibiotic treatment class started within the last 24 hrs), n = 20.
Fiberoptic bronchoscopy with quantitative protected specimen brush cultures, bronchoalveolar lavage cultures, and intracellular organism counts of bronchoalveolar lavage cells.
The diagnosis of ventilator-associated pneumonia was made in 35 cases, based on histology (n = 2), cavitation (n = 2), blood cultures (n = 4), or outcome under appropriate antibiotic treatment (n = 27). The discriminative value of the tests, based on the area under the receiver operating characteristic curve, was high (> or =0.85) in both current antibiotic treatment and recent antibiotic treatment patients. Sensitivities for a 5% intracellular organism count of bronchoalveolar lavage cells, a protected specimen brush culture threshold of 10(3) colony-forming units (cfu)/mL, and a bronchoalveolar lavage culture threshold of 10(5) cfu/mL were as follows, respectively, in the three groups: 0.71, 0.88, and 0.71 (no antibiotic treatment group); 0.5, 0.77, and 0.83 (current antibiotic group); and 0.67, 0.40, and 0.38 (recent antibiotic group). Specificity was consistently > or =0.9. In the recent antibiotic group, protected specimen brush and bronchoalveolar lavage cultures had lower sensitivities (p < .05), and the best threshold values for these two tests were 10(2) cfu/mL and 10(3) cfu/mL, respectively.
After recent introduction of an antibiotic treatment for suspected ventilator-associated pneumonia, protected specimen brush and bronchoalveolar lavage culture thresholds must be decreased to maintain good accuracy. In contrast, current antibiotic treatment prescribed for a prior infectious disease does not modify the diagnostic accuracy of protected specimen brush or bronchoalveolar lavage.
确定对于疑似呼吸机相关性肺炎患者,支气管镜检查样本的诊断准确性是否受到先前因既往感染接受的抗生素治疗和/或近期开始用于治疗疑似呼吸机相关性肺炎的抗生素治疗的影响。
对危重症患者的研究。
大学医院的重症监护病房。
前瞻性评估了63例疑似呼吸机相关性肺炎发作。根据先前的抗生素治疗情况,分为三组:无抗生素组(无既往抗生素治疗),n = 12;当前抗生素组(抗生素治疗开始超过72小时前),n = 31;近期抗生素组(在过去24小时内开始新的抗生素治疗类别),n = 20。
采用纤维支气管镜进行定量保护性标本刷检培养、支气管肺泡灌洗培养以及支气管肺泡灌洗细胞内微生物计数。
基于组织学(n = 2)、空洞形成(n = 2)、血培养(n = 4)或适当抗生素治疗下的结果(n = 27),35例患者被诊断为呼吸机相关性肺炎。基于受试者工作特征曲线下面积,当前抗生素治疗组和近期抗生素治疗组中各项检测的鉴别价值均较高(≥0.85)。三组中,支气管肺泡灌洗细胞内微生物计数为5%、保护性标本刷检培养阈值为10³菌落形成单位(cfu)/mL、支气管肺泡灌洗培养阈值为10⁵ cfu/mL时的敏感性分别如下:0.71、0.88和0.71(无抗生素治疗组);0.5、0.77和0.83(当前抗生素组);0.67、0.40和0.38(近期抗生素组)。特异性始终≥0.9。在近期抗生素组中,保护性标本刷检和支气管肺泡灌洗培养的敏感性较低(p < 0.05),这两项检测的最佳阈值分别为10² cfu/mL和10³ cfu/mL。
在近期开始对疑似呼吸机相关性肺炎进行抗生素治疗后,必须降低保护性标本刷检和支气管肺泡灌洗培养的阈值以维持良好的准确性。相比之下,先前针对传染病开具的当前抗生素治疗不会改变保护性标本刷检或支气管肺泡灌洗的诊断准确性。